Summary
The stock has recorded a trading volume of 6,13,846 shares,. Its Average Traded Price (ATP) is ₹230.07, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹227.20.
Religare Enterprises has an upper circuit limit of ₹276.36 and a lower circuit limit of ₹184.24. The total value traded stands at ₹14.12 CR, and the delivery percentage for the day is 57.82%.
The stock is currently traded with a market lot size of 1. Religare Enterprises also offers a dividend yield of 0%.
Religare Enterprises Share Price Chart
Religare Enterprises Share Key Metrics
Volume
6.14 L
Market Cap
7828.93 CR
LTQ@LTP
1@227.20
ATP
230.07
Var Margin
18.41 %
Circuit Range
184.24-276.36
Delivery %
57.82 %
Value
14.12 CR
ASM/GSM
No
Market Lot
1
Religare Enterprises Resistance and Support
Pivot 227.57
Resistance
First Resistance
235.64
Second Resistance
240.97
Third Resistance
249.04
Support
First Support
222.24
Second Support
214.17
Third Support
208.84
Religare Enterprises Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2024-25
- 2025-26
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Religare Enterprises Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-12 | Quarterly Results |
| 2026-08-12 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-07-11 | Preferential issue of shares |
| 2025-05-20 | Audited Results |
| 2025-02-03 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Religare Enterprises News
Religare Enterprises Ltd - 532915 - Update On The Governance Review
Religare Enterprises' board reviewed the Trilegal governance report, which found no adverse financial impact from legacy matters. Additionally, Religare Finvest resumed its lending operations in November 2026, and Care Health Insurance reported a 35% YoY growth in H1 premiums.
Nov 12 2026 19:32:21
Religare Enterprises Ltd - 532915 - Board Meeting Outcome for Board Meeting Outcome
Religare Enterprises reported a 19% YoY growth in H1 FY27 cons. total income to ₹4,717 crore, alongside a Q2 FY27 net loss of ₹97.69 crore. Subsidiaries Care Health Insurance and Religare Finvest showed steady operational growth, with the latter successfully resuming its lending operations.
Nov 12 2026 19:23:42
Religare Enterprises Ltd - 532915 - General Updates
CRISIL has upgraded the long-term credit rating of Religare Broking Limited's Rs.500 crore bank loan facilities to BBB+/Stable from BBB/Stable. The short-term rating was also upgraded to A2+ from A3+.
Nov 04 2026 19:04:40
Religare Enterprises Management
| Name | Position |
|---|---|
| Anuj Jain | Company Secretary & Compliance Officer |
| Malay Kumar Sinha | Non Executive Independent Director |
Religare Enterprises Similar Stocks
Aptus Value Housing Finance India Ltd.
195.00
3.10 (1.62%)
TSF Investments Ltd.
426.00
0.45 (0.11%)
Aavas Financiers Ltd.
1110.00
-9.70 (0.87%)
Equitas Small Finance Bank Ltd.
57.71
1.66 (2.96%)
Tourism Finance Corporation Of India Ltd.
171.85
1.67 (0.98%)
Ujjivan Small Finance Bank Ltd.
59.74
-0.87 (1.44%)
Kama Holdings Ltd.
2387.20
29.90 (1.27%)
Religare Enterprises FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in RELIGARE
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC